Scarica l'app Stockscreener
94.01
1.21%
-1.15
Dopo l'orario di chiusura:
93.60
-0.41
-0.44%
Panoramica
Notizia
Cronologia dei prezzi
Catena di opzioni
Perché AZN Giù?
Forum
Previsione
Frazionamento azionario
Storia dei dividendi
Astrazeneca PLC Borsa (AZN) Ultime notizie
Can AstraZeneca PLC (ZEG) stock sustain institutional flowsJuly 2025 Chart Watch & Fast Entry High Yield Tips - ulpravda.ru
Astrazeneca (AZN) Stock Falls Amid Market Uptick: What Investors Need to Know - sharewise.com
Can AstraZeneca PLC (Common Stock) (ZEGA) stock sustain breakout momentumRisk Management & Real-Time Stock Price Movement Reports - ulpravda.ru
Pharmacy XD Launches Nationally Licensed Direct-to-Patient Mail Order Pharmacy and Distribution Platform - Benzinga
AstraZeneca Taps Rick Suarez as US President & Head of the US Biopharmaceuticals Business Unit - Contract Pharma
AstraZeneca names insider Rick Suarez as head of US biopharmaceuticals unit - Reuters
ASTRAZENECA : Gets a Buy rating from Berenberg - MarketScreener
AstraZeneca Appoints Rick R. Suarez As Senior Vice President, US President, And Head Of US BioPharmaceuticals Business Unit - MarketScreener
AstraZeneca names Rick Suarez as US president to lead $50 billion investment By Investing.com - Investing.com UK
Why AstraZeneca is putting $50B behind a new US boss - Stock Titan
AstraZeneca plc Announces Executive Changes , Effective March 1, 2026 - MarketScreener
Is It Too Late To Consider AstraZeneca (LSE:AZN) After A 35% One-Year Rally? - Yahoo Finance UK
AstraZeneca Bets Big On America With $50B Investment, New Virginia Hub Plans Amid Pharma Tariff Jitters - MSN
Will AstraZeneca PLC (Common Stock) (ZEGA) stock profit from AI boomShort Selling Opportunities & Affordable Market Trading - ulpravda.ru
BostonGene teams up with AstraZeneca on AI-driven oncology - The Pharma Letter
My time working with the manufacturer of the AstraZeneca drug substance - substack.com
BostonGene, AstraZeneca Partner to Advance Oncology Drug Development - Contract Pharma
Check out AstraZeneca PLC's stock price (AZN-GB) in real time - CNBC
Check out AstraZeneca PLC's stock price (AZN) in real time - CNBC
AstraZeneca PLC (AZN) Stock Analysis: A Healthcare Giant With 8% Upside Potential - DirectorsTalk Interviews
AstraZeneca stock hits all-time high at 94.02 USD - Investing.com
AstraZeneca stock hits all-time high at 94.02 USD By Investing.com - Investing.com South Africa
JP Morgan expects solid AstraZeneca quarter and reassuring outlook - Proactive financial news
AstraZeneca's (AZN) Saphnelo Shows Promising Phase III Results - GuruFocus
AstraZeneca's Self-Injectable Lupus Drug Shines In Late-Stage Trial - Benzinga
Astrazeneca Study Shows Saphnelo Injection Reduces Lupus Disease Activity - marketscreener.com
Eyes on Asia: Insilico, Ipsen, AstraZeneca - BioXconomy
AstraZeneca flags positive trial data for Saphnelo as SLE treatment - MarketScreener
Haleon Shares Added, AstraZeneca Removed From Goldman Sachs European Conviction List - AskTraders.com
AstraZeneca says Saphnelo SC showed significant reduction in lupus disease activity - marketscreener.com
G-Protein Coupled Receptors (GPCRs) Market Size to Hit USD 6.04 Billion by 2032, Growing at a CAGR of 5.59% - GlobeNewswire Inc.
AstraZeneca (AZN) Dropped from Goldman Sachs' European Convictio - GuruFocus
AstraZeneca PLC $AZN Stake Boosted by Allspring Global Investments Holdings LLC - MarketBeat
The Truth About AstraZeneca plc: Why Everyone Is Suddenly Paying Attention - AD HOC NEWS
Can AstraZeneca PLC ZEG stock sustain institutional flowsMarket Weekly Review & Daily Stock Trend Reports - moha.gov.vn
Key facts: AstraZeneca lowers drug prices for Medicaid; reports share count - TradingView — Track All Markets
AstraZeneca reports total voting rights of 1.55 billion shares - Investing.com
AstraZeneca reports total voting rights of 1.55 billion shares By Investing.com - Investing.com South Africa
REGAstraZeneca PLCTotal Voting Rights - TradingView — Track All Markets
Biological Therapies for Cancer Global Markets Report 2025-2030: Merck, BMS, Roche, AstraZeneca, Johnson & Johnson, and Novartis Drive Growth Through Pipeline Expansion and Strategic CollaborationsResearchAndMarkets.com - FinancialContent
Q4 EPS Estimates for AstraZeneca Boosted by Zacks Research - MarketBeat
AZN Stock Price, Forecast & Analysis | ASTRAZENECA PLC-SPONS ADR (NASDAQ:AZN) - Chartmill
My Personal CFO LLC Acquires Shares of 38,411 AstraZeneca PLC $AZN - MarketBeat
Zacks Research Raises Earnings Estimates for AstraZeneca - MarketBeat
25,322 Shares in AstraZeneca PLC $AZN Purchased by Moody Lynn & Lieberson LLC - MarketBeat
AstraZeneca PLC (AZN) Secures EU Approval for Imfinzi - MSN
The Zacks Analyst Blog Highlights Berkshire Hathaway, AstraZeneca, Intel, Kingsway Financial and BK Technologies - Yahoo Finance
Smith Salley Wealth Management Raises Stock Holdings in AstraZeneca PLC $AZN - MarketBeat
Top Stock Reports for Berkshire Hathaway, AstraZeneca & Intel - Nasdaq
Ethic Inc. Acquires 11,638 Shares of AstraZeneca PLC $AZN - MarketBeat
Why AstraZeneca PLC (Common Stock) (ZEGA) stock appears on watchlistsHigh Frequency Trading Trends & Free Powerful Profit Generation - bollywoodhelpline.com
Valicenti Advisory Services Inc. Has $4.66 Million Holdings in AstraZeneca PLC $AZN - MarketBeat
DAVENPORT & Co LLC Increases Stake in AstraZeneca PLC $AZN - MarketBeat
AstraZeneca PLC (AZN) Stock Price Today - CoinMarketCap
AstraZeneca stock holds steady as mixed news and technicals limit major moves - Traders Union
Robbins Farley Purchases 27,582 Shares of AstraZeneca PLC $AZN - MarketBeat
AstraZeneca Reaches Settlement With MSN Labs Over Cancer Drug - Bloomberg Law News
Swedbank AB Buys 286,904 Shares of AstraZeneca PLC $AZN - MarketBeat
LSEG, Rolls-Royce, AstraZeneca and Rightmove spotlighted as investment bank eyes potential winners for 2026 - Proactive financial news
Here's Why Astrazeneca (AZN) is a Strong Value Stock - Yahoo Finance
AstraZeneca’s NSCLC combo fails to meet primary endpoint in Phase III trial - Clinical Trials Arena
Apri su Yahoo
|
Apri su Google
|
Aperto in Finviz
|
Apri in MarketWatch
|
Aperto a EDGAR
|
Aperto su Reuters
Capitalizzazione:
|
Volume (24 ore):